||chr13:105463160 - 105463160(1)
|Minor Allele Frequence
||downstream_gene_variant; intron_variant; non_coding_transcript_variant; upstream_gene_variant.
|Consequence to Transcript
||downstream_gene_variant(ENST00000610818, ENST00000613021); intron_variant(ENST00000448407); non_coding_transcript_variant(ENST00000448407); upstream_gene_variant(ENST00000329625, ENST00000375936, ENST00000471432, ENST00000473269, ENST00000488534, ENST00000489237, ENST00000559369, ENST00000595812, ENST00000600388, ENST00000601240, ENST00000618629)
|No. of Studies
||10 (Positive: 3; Negative: 7; Trend: 0)
|Overlap with SZ?
|Overlap with MDD?
SNP related studies (count: 10)
The LD data used here is based on HapMap rel#27. LD SNP pairs were selected with a threshold r2<=0.8.
SNP related genes (count: 2)
Literature-origin SNPs (count: 0)
LD-proxies (count: 3)
Overlap with SZ from cross-disorder studies (count: 3)
|Williams, N. M., 2006
||allelic P-value = 0.82 in Schizophrenia
||We found no evidence for allelic or genotypic association with any of the polymorphisms studied for schizophrenia. We observed nominally significant evidence (P=.01-.047) for allelic association with 3 of the polymorphisms for bipolar disorder and significant evidence for whole-gene association (P=.04).
||Association analysis:allele P-value = 0.352, OR=1.14, genotype P-value = 0.55, OR=1.48
||No significant association was observed in SZ.
|Detera-Wadleigh, S. D., 2006
||Fisher P-value = 0.0505 for all, P-value = 0.9667 for SCZ Only
Overlap with MDD from cross-disorder studies (count: 0)